Holderness Investments Co. acquired a new position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 800 shares of the medical research company’s stock, valued at approximately $219,000.
A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Capital Financial Planning LLC acquired a new position in shares of Thermo Fisher Scientific during the 4th quarter valued at about $27,000. Hanson McClain Inc. lifted its position in shares of Thermo Fisher Scientific by 263.9% during the fourth quarter. Hanson McClain Inc. now owns 131 shares of the medical research company’s stock worth $29,000 after purchasing an additional 95 shares in the last quarter. Truvestments Capital LLC acquired a new stake in shares of Thermo Fisher Scientific during the first quarter worth about $29,000. Capital Investment Advisory Services LLC purchased a new stake in shares of Thermo Fisher Scientific during the fourth quarter worth approximately $35,000. Finally, Liberty Wealth Management LLC purchased a new stake in shares of Thermo Fisher Scientific during the fourth quarter worth approximately $35,000. 87.89% of the stock is currently owned by institutional investors and hedge funds.
A number of analysts recently weighed in on TMO shares. BTIG Research upped their target price on shares of Thermo Fisher Scientific to $310.00 and gave the stock a “buy” rating in a research note on Tuesday, March 26th. UBS Group upped their target price on shares of Thermo Fisher Scientific to $305.00 and gave the stock a “buy” rating in a research note on Monday, March 25th. Deutsche Bank upped their target price on shares of Thermo Fisher Scientific from $275.00 to $300.00 and gave the stock a “buy” rating in a research note on Friday, March 22nd. Argus upped their target price on shares of Thermo Fisher Scientific from $285.00 to $310.00 and gave the stock a “buy” rating in a research note on Wednesday, May 1st. Finally, Bank of America restated a “buy” rating and set a $300.00 target price (up from $285.00) on shares of Thermo Fisher Scientific in a research note on Tuesday, April 16th. Two equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Buy” and an average target price of $295.92.
In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,713 shares of the stock in a transaction that occurred on Tuesday, April 30th. The shares were sold at an average price of $273.21, for a total value of $13,855,298.73. Following the transaction, the chief executive officer now directly owns 302,193 shares in the company, valued at $82,562,149.53. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Stephen Williamson sold 2,500 shares of the stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $268.29, for a total transaction of $670,725.00. Following the completion of the transaction, the chief financial officer now owns 40,029 shares in the company, valued at $10,739,380.41. The disclosure for this sale can be found here. Insiders sold 53,488 shares of company stock worth $14,600,474 over the last quarter. 0.45% of the stock is currently owned by insiders.
Shares of Thermo Fisher Scientific stock opened at $285.26 on Monday. The company has a market capitalization of $114.10 billion, a price-to-earnings ratio of 25.65, a P/E/G ratio of 1.87 and a beta of 1.08. Thermo Fisher Scientific Inc. has a 52 week low of $202.83 and a 52 week high of $288.07. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.16 and a current ratio of 1.69.
Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, April 24th. The medical research company reported $2.81 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.74 by $0.07. The company had revenue of $6.13 billion for the quarter, compared to analyst estimates of $6.04 billion. Thermo Fisher Scientific had a net margin of 12.89% and a return on equity of 17.06%. The firm’s revenue was up 4.6% on a year-over-year basis. During the same period in the prior year, the firm posted $2.50 earnings per share. Analysts anticipate that Thermo Fisher Scientific Inc. will post 12.2 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 16th. Shareholders of record on Friday, June 14th will be paid a $0.19 dividend. The ex-dividend date is Thursday, June 13th. This represents a $0.76 annualized dividend and a yield of 0.27%. Thermo Fisher Scientific’s dividend payout ratio is currently 6.83%.
TRADEMARK VIOLATION WARNING: “Holderness Investments Co. Invests $219,000 in Thermo Fisher Scientific Inc. (NYSE:TMO)” was originally posted by Stock Observer and is owned by of Stock Observer. If you are accessing this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright laws. The legal version of this article can be read at https://www.thestockobserver.com/2019/06/17/holderness-investments-co-invests-219000-in-thermo-fisher-scientific-inc-nysetmo.html.
Thermo Fisher Scientific Profile
Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.
Featured Story: What is the Dividend Aristocrat Index?
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.